<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (visceral <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>) resembles <z:e sem="disease" ids="C0010481" disease_type="Disease or Syndrome" abbrv="">Cushing's Syndrome</z:e>, but without elevated circulating <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> levels </plain></SENT>
<SENT sid="1" pm="."><plain>An emerging concept suggests that the aberrantly elevated levels of the intracellular <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> reamplifying enzyme 11 beta-<z:chebi fb="0" ids="35350">hydroxysteroid</z:chebi> dehydrogenase type 1 (11 beta-HSD-1) found in adipose tissue of <z:mp ids='MP_0001261'>obese</z:mp> humans and rodents underlies the phenotypic similarities between idiopathic and "Cushingoid" <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Transgenic overexpression of 11 beta-HSD-1 in adipose tissue reproduces a <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in mice, whereas 11 beta-HSD-1 deficiency or inhibition has beneficial metabolic effects, at least on liver metabolism </plain></SENT>
<SENT sid="3" pm="."><plain>Here we report novel protective effects of 11 beta-HSD-1 deficiency on adipose function, distribution, and gene expression in vivo in 11 beta-HSD-1 nullizygous (11 beta-HSD-1(-/-)) mice </plain></SENT>
<SENT sid="4" pm="."><plain>11 beta-HSD-1(-/-) mice expressed lower resistin and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, but higher peroxisome proliferator-activated receptor-gamma, adiponectin, and uncoupling protein-2 mRNA levels in adipose, indicating insulin sensitization </plain></SENT>
<SENT sid="5" pm="."><plain>Isolated 11 beta-HSD-1(-/-) adipocytes exhibited higher basal and insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake </plain></SENT>
<SENT sid="6" pm="."><plain>11 beta-HSD-1(-/-) mice also exhibited reduced visceral fat accumulation upon high-fat feeding </plain></SENT>
<SENT sid="7" pm="."><plain>High-fat-fed 11 beta-HSD-1(-/-) mice rederived onto the C57BL/6J strain resisted <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:mp ids='MP_0005456'>weight gain</z:mp> despite consuming more calories </plain></SENT>
<SENT sid="8" pm="."><plain>These data provide the first in vivo evidence that adipose 11 beta-HSD-1 deficiency beneficially alters adipose tissue distribution and function, complementing the reported effects of hepatic 11 beta-HSD-1 deficiency or inhibition </plain></SENT>
</text></document>